Vytelle doubles its bovine IVF lab capacity; outpacing goals since its $13.2M round
December 1, 2022 | Startland News Staff
A five-year plan initiated by Vytelle’s Series A funding round called for the agtech startup to double its laboratory capacity to produce bovine embryos through in vitro fertilization. Just a year later, the Lenexa-headquarted company already has opened its fifth new lab.
Vytelle’s latest facility — in Franklin, Tennessee — is accessible to beef and dairy seedstock producers through on-farm ovum pick-ups and satellite locations, the startup detailed, noting previously opened labs in Albany, New York; Fort Worth, Texas; and Gainesville, Florida; in addition to Hamilton, New Zealand.
Click here to learn more about Vytelle’s $13.2 oversubscribed round in 2021, which included backing from Kansas City venture capital firm KCRise Fund.
“Vytelle is the fastest growing bovine IVF company in the world,” said Kerryann Kocher, CEO of Vytelle. “Producers are accelerating genetic progress — replicating their elite animals with hormone-free IVF. This last lab places Vytelle within reach of 50 percent of the US breeding stock, making hormone-free technology more accessible to our customers.”
RELATED: KC capital implants cattle tech startup with fuel to scale, expanding IVF labs, headcount

Vytelle is an integrated technology platform built to accelerate genetic progress in cattle; photo courtesy of Vytelle
Vytelle’s platform combines Vytelle ADVANCE, a breakthrough IVF technology, with Vytelle SENSE, an animal performance data capture system, and Vytelle INSIGHT, an artificial intelligence-based genetic analytics engine.
The platform provides progressive cattle producers the technology to make reliable data-driven mating decisions that improve the predictability of genetic progress replicating the right genetics faster.
Producers are able to access Vytelle’s bovine hormone-free IVF process by bringing donors to any of the more than 30 satellite locations across the United States or by scheduling an on-farm ovum pick-up.
Click here to learn more about Vytelle, an integrated technology platform built to accelerate genetic progress in cattle.
This story is possible thanks to support from the Ewing Marion Kauffman Foundation, a private, nonpartisan foundation that works together with communities in education and entrepreneurship to create uncommon solutions and empower people to shape their futures and be successful.
For more information, visit www.kauffman.org and connect at www.twitter.com/kauffmanfdn and www.facebook.com/kauffmanfdn

2022 Startups to Watch
stats here
Related Posts on Startland News
NXTSTAGE taps trio of KC entrepreneurs to help their companies grow revenue, scale
WICHITA — Three Kansas City startup founders are among 20 early-stage companies selected for the latest NXTUS program aimed at boosting innovation from within urban and rural areas throughout the state of Kansas. Joining the 2024 NXTSTAGE Customer Traction Cohort: Joy Broils, Hustle & Ground, Shawnee; Mark Lukenbill, Mpruv Sports, Basehor; and Crystal Webster, Sharing…
Study with USDA researchers affirms startup’s AI-powered facial recognition for cows can detect sick animals
A collaborative study between an Overland Park animal agtech startup and the U.S. Department of Agriculture successfully corroborated MyAnIML’s predictive ability to proactively manage devastating disease outbreaks in cattle production, the company announced this week. MyAnIML uses first-of-its-kind, proprietary facial recognition and deep learning technology to analyze cow muzzles — accurately predicting Infectious Bovine Keratoconjunctivitis…
KC startup’s bone cancer treatment for dogs earns ‘milestone’ USDA validation
A decade of hard work by a veteran entrepreneur and her Olathe-based team has cleared a significant hurdle on the pathway to licensure as its first-in-class adoptive cell therapy for dog cancer gains a critical nod of approval from federal regulators. ELIAS Animal Health, a leading companion animal cancer therapeutics company, recently announced that the…


